Nitro Pohl (Glyceryl Trinitrate)

• Nitro Pohl (glyceryl trinitrate) is used in the management of acute coronary and cardiovascular emergencies, where rapid vasodilation is required.
• Acute angina pectoris: provides rapid relief of chest pain by reducing myocardial oxygen demand and preload.
• Myocardial infarction (adjunct therapy): improves coronary blood flow and decreases left‑ventricular workload during acute MI.
• Acute heart failure: lowers ventricular filling pressures and systemic vascular resistance, aiding symptom control.
• Hypertensive emergencies: produces prompt arterial dilation to rapidly lower elevated blood pressure.

• Glyceryl trinitrate is enzymatically reduced to nitric oxide within vascular smooth muscle cells. The released nitric oxide activates soluble guanylate cyclase, increasing cyclic GMP levels, which leads to relaxation of smooth muscle and vasodilation of both veins and arteries. This reduces preload and afterload, decreasing myocardial oxygen consumption and improving coronary perfusion during acute cardiac events.

Glyceryl trinitrate may cause a range of adverse reactions, varying from mild to severe, that clinicians monitor during therapy.

Common Side Effects

• Headache: throbbing pain often triggered by cerebral vasodilation.
• Hypotension: transient drop in blood pressure, especially with rapid infusion.
• Flushing: warm, reddened skin sensation commonly on the face and neck.
• Dizziness or light‑headedness: related to reduced cerebral perfusion.
• Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects

• Severe hypotension: profound blood pressure fall requiring emergency intervention.
• Methemoglobinemia: elevated methemoglobin levels causing cyanosis and hypoxia.
• Anaphylaxis or severe allergic reaction: rapid onset of airway swelling, rash, and circulatory collapse.
• Myocardial ischemia worsening: paradoxical reduction in coronary perfusion in certain patients.
• Refractory shock: unresponsive circulatory failure despite standard measures.

• When using Nitro Pohl, clinicians should observe specific safety measures to minimize risks.
• Monitor blood pressure continuously: adjust infusion rate to avoid excessive hypotension.
• Avoid concurrent use with other nitrates or phosphodiesterase‑5 inhibitors: risk of severe vasodilation.
• Use with caution in patients with severe anemia or hypovolemia: increased susceptibility to hypotension.
• Adjust therapy in severe aortic stenosis or hypertrophic cardiomyopathy: fixed outflow obstruction may worsen.
• Assess for tolerance development: prolonged use may reduce efficacy.
• Store at room temperature: keep in original container, protect from moisture and direct light.

Glyceryl trinitrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Sildenafil, tadalafil, or other PDE‑5 inhibitors: additive vasodilatory effect leading to profound hypotension.
• Other organic nitrates (e.g., isosorbide dinitrate): risk of severe blood pressure collapse.
• Riociguat: synergistic nitric oxide pathway activation causing dangerous hypotension.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may blunt compensatory tachycardia, necessitating blood pressure monitoring.
• ACE inhibitors or ARBs: combined effect on vascular tone may require dose adjustments.